Amy Furlong joined IDDI as president, board of directors, leveraging her 30-year career in the clinical research industry. Currently, Amy serves as a strategic consultant to clinical technology and service organizations in the life sciences industry supporting product innovation, operational scalability, and value creation through strategic planning and execution. Previously, she also served as COO at YourEncore (acquired by Advarra) leading a successful organizational transformation. Amy spent 20 years at ERT (now Clario) as executive VP, cardiac safety and eClinical product lines and former COO driving new market share, creating synergistic savings and growth through global acquisitions, and building scalable quality-focused operations.

Amy earned a Master of Science in quality assurance & regulatory affairs and a Bachelor of Science in biology from Temple University. She has been named among Pennsylvania National Diversity Council’s 2016 Most Influential Women. Amy has been published as a contributor in Cardiac Safety of Noncardiac Drugs Practical Guidelines for Clinical Research & Drug Development.

Back to Team